quinazolines has been researched along with Granuloma, Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, C; Kimura, M; Mori, N; Okano, Y; Senba, M | 1 |
| Cochet, O; Frelin, C; Imbert, V; Peyron, JF | 1 |
2 other study(ies) available for quinazolines and Granuloma, Hodgkin
| Article | Year |
|---|---|
Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
Topics: Animals; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Base Sequence; Blotting, Western; Burkitt Lymphoma; Cell Cycle; DNA Primers; Hodgkin Disease; Humans; Immunohistochemistry; Mice; Mice, Inbred NOD; Mice, SCID; Organophosphates; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.
Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Electrophoretic Mobility Shift Assay; Hodgkin Disease; Humans; Immunoprecipitation; Quinazolines; RNA, Small Interfering; Signal Transduction; STAT Transcription Factors; Tumor Cells, Cultured; Tyrphostins | 2006 |